Home/Filings/4/0000899866-20-000091
4//SEC Filing

Chiniara Ellen 4

Accession 0000899866-20-000091

CIK 0000899866other

Filed

Dec 17, 7:00 PM ET

Accepted

Dec 18, 5:02 PM ET

Size

9.7 KB

Accession

0000899866-20-000091

Insider Transaction Report

Form 4
Period: 2020-12-16
Chiniara Ellen
EVP & General Counsel
Transactions
  • Award

    Common Stock, par value $.0001 per share

    2020-12-16+37,96562,917 total
  • Tax Payment

    Common Stock, par value $.0001 per share

    2020-12-16$157.96/sh2,988$471,98443,004 total
  • Award

    Common Stock, par value $.0001 per share

    2020-12-15$95.53/sh+56$5,35043,060 total
  • Tax Payment

    Common Stock, par value $.0001 per share

    2020-12-16$157.96/sh16,925$2,673,47345,992 total
Footnotes (4)
  • [F1]Shares acquired on vesting of Performance Stock Units previously granted on February 28, 2018 under the 2017 Stock Incentive Plan.
  • [F2]This sale was made to cover withholding taxes immediately following the vesting of previously granted Performance Stock Units.
  • [F3]This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units.
  • [F4]In accordance with the Alexion ESPP, these shares were purchased (for the ESPP purchase period from July 1, 2020 to December 15, 2020) based on 85% of the share price on July 1, 2020.

Issuer

ALEXION PHARMACEUTICALS, INC.

CIK 0000899866

Entity typeother

Related Parties

1
  • filerCIK 0001398764

Filing Metadata

Form type
4
Filed
Dec 17, 7:00 PM ET
Accepted
Dec 18, 5:02 PM ET
Size
9.7 KB